Sanofi Logo

Sanofi

Global biopharma firm researching, developing & marketing prescription medicines & vaccines.

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 6.4 MB
2025-10-06 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 6.3 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-29 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.4 MB
2025-09-22 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.6 MB
2025-09-15 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 444.0 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - A…
English 136.1 KB
2025-09-12 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT …
French 112.1 KB
2025-09-02 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.9 MB
2025-09-02 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.9 MB
2025-08-25 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-08-18 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.7 MB
2025-08-18 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juill…
French 121.9 KB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.